Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

SOTKAMO SILVER PROPOSES SHARE ISSUES OF IN AGGREGATE APPROX. EUR 20M TO STRENGTHEN ITS FINANCIAL POSITION

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN OR INTO AUSTRALIA, CANADA, HONG KONG, JAPAN, SINGAPORE, SOUTH AFRICA, NEW ZEALAND, THE UNITED STATES OR ANY OTHER COUNTRY WHERE SUCH PUBLICATION, DISTRIBUTION OR RELEASE WOULD BE UNLAWFUL OR REQUIRE ADDITIONAL DOCUMENTS TO BE PREPARED OR REGISTERED OR REQUIRE ANY OTHER ACTIONS TO BE TAKEN, IN ADDITION TO THE REQUIREMENTS UNDER SWEDISH LAW. THIS PRESS RELEASE IS NOT A PROSPECTUS OR AN OFFER FOR SALE OF SECURITIES. SECURITIES MAY NOT BE SOLD IN THE UNITED STATES ABSENT REGISTRATION WITH THE UNITED

Pemamek to deliver PEMA onshore wind tower production lines to Al Yamamah

Al Yamamah Steel Industries has selected Pemamek to supply high-capacity PEMA onshore wind tower production equipment to the company’s Al-Yamamah Wind Energy Systems Factory. The machinery is scheduled to be delivered in early 2023. Example of PEMA wind tower production line. Photo by Pemamek. The Finnish welding and production automation company Pemamek Ltd. has signed a contract with Al Yamamah Steel Industries to supply PEMA onshore wind tower manufacturing lines. The newly made order is a part of the construction project of the Al-Yamamah Wind Energy Systems Factory which

Resolutions at Swedish Stirling’s Extraordinary General Meeting 2022

At the Extraordinary General Meeting (the “EGM”) of Swedish Stirling AB (publ) on 28 November 2022, which was held through postal voting without physical presence in accordance with temporary legislation, the following was resolved. All resolutions were in accordance with the submitted proposals, described in detail in the general meeting documents available on the company’s website, www.swedishstirling.com.Authorisation for the Board of Directors to resolve on new issue of ordinary sharesThe EGM resolved, in accordance with the proposal of the Board of Directors, to authorise the Board

Penneo issues 2023 employee share program

Company Announcement No. 32-2022 Copenhagen, 28 November 2022The Board of Directors has in close collaboration with the executive management in Penneo decided to offer an employee share program. The purpose of the program is to: · Ensure aligned interests between employees and the shareholders of the company · Retain employees The employee share program applies to all current full time employees in Penneo. The employee share program makes it possible for Penneo employees to have part of their salaries paid in Penneo shares. Penneo’s own shares will be used for the share

BioStock: Arcede Pharma’s RCD405 well tolerated

Lund-based Arcede Pharma is working hard to complete the preclinical work on the drug candidate RCD405. The company now reports the first part of the toxicological program and notes that the substance is well tolerated. BioStock contacted the company’s CEO Mia Lundblad to find out more about what this means for the project and about the next step.Read the full article at biostock.se: https://www.biostock.se/en/2022/11/arcede-pharmas-rcd405-well-tolerated/ This is a press release from BioStock - Connecting Innovation & Capital. https://www.biostock.se

ENHANCE Alliance welcomes three new member universities, to form a powerhouse of education and research

TU Delft University of Technology, Gdańsk University of Technology and ETH Zurich join the ENHANCE Alliance on its journey towards a European University. The ENHANCE Alliance is delighted to welcome TU Delft University of Technology (Netherlands), Gdańsk University of Technology (Poland) and ETH Zurich (Switzerland) as new members. High-ranked representatives of all three institutions have joined the ENHANCE Leadership Meeting, held on Friday, 25 November 2022 at RWTH Aachen University. The ten member universities were handed their signed Memorandums of Understanding, which

Peab has completed the repurchase of own shares

Peab AB (publ) has repurchased 7,511,000 shares for around SEK 500 million between May 20 and November 18, 2022. Repurchasing has taken place after a decision by the Board, supported by authorization from the Annual General Meeting on May 5, 2022.Repurchasing commenced on May 20, 2022 and took place regularly until November 18, 2022 when shares for a total of around SEK 500 million had been repurchased, equaling a total of 7,511,000 B shares. The shares were repurchased on Nasdaq Stockholm according to the Nordic Main Market Rulebook for Issuers of Shares – Nasdaq Stockholm (Supplement D)

Repurchase of Outokumpu’s own shares

Outokumpu OyjStock exchange releaseNovember 28, 2022, at 9.00 am EETRepurchase of Outokumpu’s own shares On November 25, 2022, Outokumpu has completed repurchases its own shares as follows (ISIN FI0009002422): +-------+----------------+------------------------------------+----------------+|Trading|Number of shares|Weighted average price / share, EUR*|Total cost, EUR*||venue | | | |+-------+----------------+------------------------------------+----------------+|CEUX |75,489 |4.6783

GomSpace (provider of nanosatellites) announces its quarterly results for the third quarter 2022

Stockholm, November 28, 2022. GomSpace Group AB (the “Company”) announces its interim report for the third quarter of 2022. The report is available on the Company’s homepage (www.gomspace.com). The following is taken from the quarterly report: Third quarter summary 1 July – 30 September 2022 (2021) · Order intake increased by 22% to T.SEK 52,639 (43,034) · We suspended a large customer project resulting in a canceled order value of T.SEK 76,895, with a negative effect on revenue, gross margin, and gross profit (EBIT) · Net revenues decreased to T.SEK 18,102 (49,700) ·

Toivo Group Oyj - Managers' Transactions - Asko Myllymäki

Toivo Group Oyj - Managers' Transactions - 28 November 2022 at 8:15 a.m. ____________________________________________ Person subject to the notification requirement Name: Asko Myllymäki Position: Member of the Board/Deputy member Issuer: Toivo Oyj LEI: 743700N31WYJDNPT8M98 Notification type: INITIAL NOTIFICATION Reference number: 21424/5/6 ____________________________________________ Transaction date: 2022-11-23 Venue: FIRST NORTH GROWTH MARKET FINLAND (FSME) Instrument type: SHARE ISIN: FI4000496716 Nature of the transaction: ACQUISITION

AMSC ASA - Ex-dividend today

Lysaker, 28 November 2022, Ex-dividend today Reference is made to the Company's Q3 2022 report, regarding the Board's authorization to pay a quarterly dividend of USD 0.12 per share to the shareholders of AMSC on record as of 29 November 2022.  The shares in AMSC ASA will be traded ex dividend USD 0.12 as from today, 28 November 2022.  The NOK amount per share will be 1.1912 and will be paid on or about 7 December 2022.  The dividend is classified as a return of paid in capital. *** About AMSC ASA: Established in 2005 and listed on the Euronext Oslo Stock Exchange, AMSC is a

Changes in Raute Executive Board and new organizational structure as of 1 January 2023

RAUTE CORPORATION STOCK EXCHANGE RELEASE NOVEMBER 28, 2022 at 8:00 a.m. CHANGES IN RAUTE EXECUTIVE BOARD AND NEW ORGANIZATION STRUCTURE AS OF 1 JANUARY 2023  Raute is entering a new phase in its strategic journey to create value in forest assets. To better address the current operational and strategic development plans, Raute will change its organization structure. The new structure will strengthen Raute’s ability to service customers and streamlines internal operations. The change will also be reflected in the Executive Board composition and responsibility areas.   As of 1

Noble Corporation plc announces changes to its share capital

SUGAR LAND, Texas, Nov. 26, 2022 /PRNewswire/ -- Noble Corporation plc ("Noble") (CSE: NOBLE, NYSE: NE) today announces changes to its share capital. 3,170 A ordinary shares with a nominal value of USD 0.00001 each (the "Excess Shares") issued by Noble in connection with the completion of the compulsory purchase of the remaining outstanding shares of The Drilling Company of 1972 A/S ("Maersk Drilling") (the "Compulsory Purchase") have been cancelled. As further described in the Notice concerning the compulsory purchase to the shareholders of Maersk Drilling pursuant to sections 70-72

US Partial Clinical Hold on Diamyd® Phase III Trial Lifted by the FDA

Diamyd Medical announced today that the U.S. Food and Drug Administration (FDA) has lifted the partial clinical hold on the confirmatory Phase III trial DIAGNODE-3, evaluating the safety and efficacy of the precision medicine and antigen-specific immunotherapy Diamyd[® ]in individuals recently diagnosed with type 1 diabetes. Following the decision from the FDA, DIAGNODE-3 is approved to start in the US.“This is a significant milestone for Diamyd Medical and more importantly, for patients diagnosed with type 1 diabetes,” comments Ulf Hannelius, CEO of Diamyd Medical. “We are looking forward

Nordea Bank Abp: Repurchase of own shares on 25.11.2022

Nordea Bank AbpStock exchange release – Changes in company’s own shares25.11.2022 at 22.30 EET Nordea Bank Abp (LEI: 529900ODI3047E2LIV03) has on 25.11.2022 completed repurchases of own shares (ISIN: FI4000297767) as follows: Trading Number Weighted average Total cost, EUR* **venue (MIC of price / share, EUR* Code) shares **XHEL 127,241 10.09 1,283,734.45CEUX 128,426 10.09 1,295,378.50TQEX 18,229 10.09  183,877.53XSTO 121,421 10.08  1,224,478.39

ODI Pharma AB publishes the annual report for the fiscal year 2021/2022

The Board of Directors and the Chief Executive Officer of ODI Pharma AB (“ODI Pharma”) hereby publishes the annual report for the fiscal year 2021/2022. The annual report, along with the accompanying auditor’s report, is available as an attached file and on the websites of ODI Pharma (www.odipharma.com) and Spotlight Stock Market (www.spotlightstockmarket.com). A Swedish translation of the annual report is also available on www.odipharma.com.For more information on ODI Pharma, please contact: Derek Simmross, CEO, ODI Pharma AB E-mail: info@odipharma.com   ODI Pharma AB ODI

NanoCap's holding MyFirstApp Group enters into an agreement to divest its operations to ObsteCare

Stockholm 2022-11-25 NanoCap's holding MyFirstApp Group has entered into an agreement to divest its business within Ed-Tech to ObsteCare AB. The purchase price amounts to SEK 22 million, of which SEK 9.7 million is to be paid through newly issued shares in ObsteCare at a rate of SEK 0.05 per share and SEK 12.3 million through reversion. An additional purchase price of a maximum of SEK 10 million must be paid to the seller depending on performance. The additional purchase price is paid 50 percent in the form of shares and 50 percent in cash. The deal is conditional on ObsteCare`s

Elkem ASA – Sale of shares under share incentive programme

Oslo, 25 November 2022 Reference is made to the previous stock exchange release on 25 November 2022, regarding exercise of share options under Elkem ASA's ("Elkem" or the "Company", OSE ticker code: "ELK") share incentive programme. Pursuant to the sales process conducted by a third party Frédéric Jacquin (SVP Strategy & Business Development), has sold 50,000 shares at a price of NOK 35.1577 per share, following which he holds 408,380 options and 81,551 shares in the Company.   Further details of the primary insider transactions pursuant to the market abuse regulation article 19

Profit warning: Toivo Group Plc reduces its guidance due to the change in the market's yield requirements

Company release, inside information, 25 November 2022 at 7.20 p.m. Toivo Group Oyj ("Toivo" or "Company") reduces its guidance for the year 2022. Due to the rise in market interest rates, Toivo's external valuator estimates that the yield requirements for apartments will increase in the fair value review carried out before the end of the year. Correspondingly, for example, increases in apartment rents at the turn of the year support apartment valuation levels. The company's operational processes have been implemented during the 2022 financial year almost as planned. The estimated

GomSpace enters a convertible loan agreement of SEK 53.6 million and the board of directors intends to resolve on a rights issue of between SEK 100 to 125 million

GomSpace Group AB (publ) (”GomSpace” or the ”Company”) has entered a convertible loan agreement of SEK 53.6 million and announces the intention of the board of directors of the Company to resolve on a rights issue of between SEK 100 to 125 million (the “Rights Issue”). The terms and conditions for the Rights Issue will be announced following a decision by the board of directors to carry out the Rights Issue, indicatively during first quarter of 2023, with the intention to have the loan amount of SEK 53.6 million converted into new shares in the Rights Issue. The convertible loan is part of

Oncopeptides enters into a renewed loan facility agreement of up to €30 million with the European Investment Bank

STOCKHOLM — November 25, 2022 — Oncopeptides AB (publ) (Nasdaq Stockholm: ONCO), a biotech company focused on research and development of therapies for difficult-to-treat hematological diseases, today announced that the company has entered into a renewed unsecured loan facility agreement with the European Investment Bank (EIB), granting access to a conditional loan facility of up to €30 million.The loan facility agreement is divided into three tranches, each with a maturity of five years, which will become available if the company satisfies certain conditions precedent, including reaching

GomSpace signs EUR 18 million credit facility agreement with the European Investment Bank

Today, GomSpace A/S (a wholly-owned Danish subsidiary of GomSpace Group AB) has signed a finance contract through which the European Investment Bank (the “EIB”), upon certain conditions, makes available a venture debt facility of up to EUR 18 million to GomSpace A/S for a research and development project relating to an enlarged satellite platform, part of the product investment program announced by GomSpace earlier in 2022. If GomSpace utilizes the facility, the EIB will be entitled to a predetermined number of warrants in GomSpace Group AB for each tranche. Today, GomSpace A/S (a wholly-

Interim report for the period 1 July 2022 – 30 September 2022

published at 17:30 on 25 November 2022 Wicket Gaming AB (”Wicket Gaming” or the ”Company”) publishes interim report for the period 1 July 2022 – 30 September 2022.Summary of the period Third quarter 01/07/2022 – 30/09/2022 - Net sales: SEK 5 thousand (0). - Earnings before interest, taxes, depreciation and amortisation (EBITDA): SEK -3,462 thousand (-2,137). - Net loss after financial items: SEK -3,958 thousand (-2,139). - Earnings per share: SEK -0.61 (-0.40) before dilution and SEK -0.55 (-0.39) after dilution. - Investments during the period amounted to SEK -5,869

There are no items matching the current filter
There are no more items matching the current filter
Back to top